Literature DB >> 11460573

Thyroid hormone excess and glucose intolerance.

G D Dimitriadis1, S A Raptis.   

Abstract

The elevated plasma glucose levels in hyperthyroidism may be explained by increased rates of endogenous glucose production, due mainly to increased gluconeogenesis. The rates of insulin-stimulated glucose disposal in peripheral tissues in hyperthyroidism have been found, in general, either normal or increased. Skeletal muscle is the most important tissue for the disposal of glucose in response to insulin. In this tissue, insulin increases glucose disposal by stimulating glucose transport, glucose phosphorylation/glycolysis, glycogen synthesis and glucose oxidation. Studies examining insulin-stimulated glucose metabolism in skeletal muscle have suggested that, in the hyperthyroid state, it may be of primary importance to increase the rates of glycolysis and lactate formation relative to glucose oxidation in this tissue in order to provide substrate for gluconeogenesis (increase Cori cycle activity). This effect will be achieved primarily by a decrease in glycogen synthesis and an increase in glycogenolysis. When hyperthyroidism becomes more severe, an increased rate of glucose uptake into muscle may then be necessary since the increased conversion of glycogen to lactate could not be sustained for prolonged periods and might lead to a depletion in glycogen stores. This mechanism would ensure that the level of glucose in plasma is kept normal or slightly increased. Thus, an increased Cori cycle activity may be a necessary mechanism to provide optimal conditions in hyperthyroidism for the control of glucose utilization without increasing the risk of hypoglycemia. In addition to lactate, increased rates of gluconeogenesis in hyperthyroidism can also be sustained by increased plasma concentrations of amino acids (mostly glutamine and alanine) and glycerol, as well as by increased plasma concentrations of free fatty acids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460573     DOI: 10.1055/s-2001-18584

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  37 in total

1.  Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.

Authors:  Silvania Silva Teixeira; Akhilesh K Tamrakar; Francemilson Goulart-Silva; Caroline Serrano-Nascimento; Amira Klip; Maria Tereza Nunes
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

Review 2.  Brain-liver connections: role of the preautonomic PVN neurons.

Authors:  James D O'Hare; Andrea Zsombok
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-08       Impact factor: 4.310

3.  Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men.

Authors:  Wang Li; Chen Changsheng; Fu Jiangfang; Gao Bin; Zhang Nanyan; Li Xiaomiao; Li Deqiang; Xing Ying; Zai Wensong; Ji Qiuhe
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

4.  Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1.

Authors:  Maria Sjögren; Anneke Alkemade; Jens Mittag; Kristina Nordström; Abram Katz; Björn Rozell; Håkan Westerblad; Anders Arner; Björn Vennström
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

5.  Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice.

Authors:  Livia López-Noriega; Nadia Cobo-Vuilleumier; Álvaro Jesús Narbona-Pérez; Juan Luis Araujo-Garrido; Petra Isabel Lorenzo; José Manuel Mellado-Gil; José Carlos Moreno; Benoit R Gauthier; Alejandro Martín-Montalvo
Journal:  Br J Pharmacol       Date:  2017-09-20       Impact factor: 8.739

Review 6.  Thyroid hormones and the metabolic syndrome.

Authors:  K Alexander Iwen; Erich Schröder; Georg Brabant
Journal:  Eur Thyroid J       Date:  2013-05-28

Review 7.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

8.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

9.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.